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Background:  The  effects  of cardiac  rehabilitation  (CR)  on muscle  mass,  muscle  strength,  and  exercise
tolerance  in patients  with  diabetes  mellitus  (DM)  who  received  CR after  coronary  artery  bypass  grafting
(CABG)  have  not  been  fully  elucidated.
Methods:  We  enrolled  78  consecutive  patients  who  completed  a supervised  CR for 6 months  after  CABG
(DM  group,  n =  37;  non-DM  group,  n  = 41).  We  measured  mid-upper  arm  muscle  area  (MAMA),  handgrip
power  (HGP),  muscle  strength  of  the  knee  extensor  (Ext)  and  ﬂexor  (Flex),  and  exercise  tolerance  at  the
beginning  and  end  of CR.
Results:  No  signiﬁcant  differences  in  confounding  factors,  including  age, gender,  ejection  fraction,  or
number  of  CR  sessions,  were  observed  between  the  two  groups.  At  the beginning  of  CR, the  levels  of  Ext
muscle  strength  and  peak  VO2 were  signiﬁcantly  lower  in  the  DM  group  than  in  the  non-DM  group.  At
the end  of  CR,  signiﬁcant  improvement  in  the  levels  of muscle  strength,  HGP,  and  exercise  tolerance  was
observed  in  both  groups.  However,  the  levels  of  Ext muscle  strength,  HGP,  peak  VO2, thigh  circumference,
and  MAMA  were  signiﬁcantly  lower  in  the  DM  group  than  in the  non-DM  group.  In  addition,  no  signiﬁcant
improvement  in thigh  circumference  and  MAMA  was  observed  in  the DM  group.  At  the  end  of  CR,  the
levels  of  thigh  circumference  and  MAMA  correlated  with  Ext and  Flex  muscle  strength  as  well  as  with
HGP.  Percent  changes  in  the  levels  of Ext  muscle  strength  were  signiﬁcantly  correlated  with  those  of
MAMA  and  hemoglobin  A1c.
Conclusions:  These  data  suggest  that  improvement  in  muscle  strength  may  be  inﬂuenced  by changes  in
muscle  mass  and  high  glucose  levels  in DM  patients  undergoing  CR after  CABG.  A CR  program,  including
muscle  mass  intervention  and  blood  glucose  control,  may  improve  deterioration  in  exercise  tolerance  in
DM  patients  after  CABG.
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Patients with diabetes mellitus (DM) are at increased risk of
oronary artery disease (CAD) [1].  Patients with DM are at 2–4 times
igher risk of developing CAD and mortality due to CAD compared
ith non-DM patients [2]. Patients with CAD are treated by life-
tyle modiﬁcation, medical therapy, and coronary revascularization
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such as percutaneous coronary intervention and coronary artery
bypass grafting (CABG). However, the beneﬁts of revascularization
are less and the risks and complications are greater than those in
non-DM patients. Previous studies have also reported a high inci-
dence of bypass graft dysfunction and a high mortality even in DM
patients who  underwent CABG [3].
Cardiac rehabilitation (CR) has numerous beneﬁts such as mod-
iﬁcation of risk factors and prevention of future cardiovascular
events [4].  Improvement in peak VO2 after CR reduced cardiovas-
cular morbidity and mortality in patients with CAD [5].  However, a
previous study demonstrated that the presence of DM was a nega-
tive factor for improvement in peak VO2 [6].  Another report showed
a signiﬁcant inverse relationship between fasting blood glucose
vier Ltd. All rights reserved.
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use of drugs, including antiplatelets, calcium channel blockers, -
blockers, angiotensin-converting enzyme inhibitors, angiotensin
II receptor blockers, or statins, were observed between the two
groups. In the DM group, 24 patients (65%) and 13 patients (35%)
Table 1
Clinical characteristics of the study subjects.
DM Non-DM p-Value
N 37 41
Age (year) 63.5 ± 10 64.1 ± 9 NS
Male (%) 29 (78) 39 (95) NS
Hypertension (%) 22 (61) 30 (73) NS
Dyslipidemia (%) 28 (76) 31 (76) NS
Current smoker (%) 17 (49) 21 (53) NS
Familial history (%) 11 (26) 9 (26) NS
History of MI  (%) 2 (5) 0 (0) NS
History of PCI (%) 2 (5) 0 (0) NS
History of previous CABG (%) 1 (3) 0 (0) NS
Diseased vessels
LMT (%) 9 (25) 2 (5) NS
3VD (%) 18 (48) 28 (68) NS
1–2VD (%) 10 (27) 11 (27) NS
Ejection fraction (%) 59.7 ± 16 65.3 ± 12 NS
Off-pump CABG (%) 36 (97) 41 (100) NSM. Nishitani et al. / Journal 
evels and changes in peak VO2 in CR participants with DM after
oronary events [7].  Park et al. reported that a low level of muscle
trength was a predictor of physical limitation, and diabetes was
ssociated with a low level of skeletal muscle strength and dete-
ioration in quality [8].  We  recently reported that muscle strength
nd exercise tolerance were signiﬁcantly lower in DM patients than
on-DM patients at the beginning of CR after CABG [9].  However,
he effects of CR on muscle mass, muscle strength, and exercise tol-
rance in DM patients undergoing CR after CABG has not been fully
lucidated. The aim of this study was to investigate the effects of
R on muscle mass, muscle strength, and exercise tolerance in DM
atients who received CR after CABG.
ethods
ubjects
We enrolled 78 consecutive patients who completed a super-
ised CR for 6 months after CABG at Juntendo University Hospital
rom July 2002 to February 2005. The patients were divided into
 groups: those with DM (DM group, n = 37) and those without
M (non-DM group, n = 41), according to the guidelines of the
apan Diabetes Society (JDS), which includes history of medical
reatment, fasting plasma glucose ≥ 126 mg/dl or casual plasma
lucose ≥ 200 mg/dl, and hemoglobin (Hb) A1c ≥ 6.1% [10]. All
atients participated in the CR program 6–8 days after CABG. All
ubjects gave written informed consent and the ethical committee
f the institution approved this study.
ehabilitation protocol
The CR program consisting of warm-up stretching, aerobic exer-
ise, resistance training, and cool-down, was scheduled once or
wice a week for 6 months, as described previously [11,12]. Aero-
ic exercise consisted of a cycle ergometer, treadmill, and walking
n an indoor track with a total duration of approximately 60 min
xercise intensity was prescribed individually at the anaerobic
hreshold (AT) level, as measured by an ergometer test using expi-
atory gas analysis or a rating of 11–13 on a standard Borg’s
erceived exertion scale. Resistance training, which was  gradually
dded to the exercise program at least 6 weeks after participation,
ncluded sit-ups, back kicks and front raises, squats, and push-ups,
sing the patient’s own weight. This training consisted of 1–2 sets of
0–15 repetitions for each muscle group with 3–5 min  rest between
ets. Patients were encouraged to perform home-based aerobic
xercise twice a week for more than 20 min  at a rating of 11–13
f perceived exertion on Borg’s scale. All subjects were instructed
o follow the phase II diet of the American Heart Association at the
eginning of CR. An educational program regarding CAD and its risk
actors at baseline was also provided for each subject by physicians,
urses, and dietitians.
easurements
We assessed body composition, muscle strength, and exer-
ise tolerance at the beginning and end of CR. Anthropometric
arameters were assessed using body mass index (BMI), waist
ize, thigh circumference, triceps skin fold thickness measured on
he dominant hand, and mid-upper arm circumference. Thigh cir-
umference was measured directly below the gluteal fold of the
ight thigh according to WHO  standards [13]. Mid-upper arm mus-
le area (MAMA) was calculated according to a standard method
14]. The percentages of body fat and lean body weight were mea-
ured by BOD POD® (Life Measurement, Inc., Concord, CA, USA), as
escribed previously [11,12].  The power of the thigh muscles was
easured using the Cybex770 system (Cybex Division of Lumex,iology 61 (2013) 216–221 217
Ronkonkoma, NY, USA), as also reported previously [11,12]. The
isokinetic peak torques of the knee extensor (Ext) and ﬂexor (Flex)
muscles were measured at 60◦/s, and those were adjusted by body
weight according to the following formula: strength (Nm) × 100/kg
body weight. Handgrip power (HGP) in the dominant hand was
also measured. To measure peak oxygen consumption (peak VO2)
and oxygen uptake at the AT, patients underwent ergometer test-
ing (Corival 400, Lobe B.V., Groningen, Netherlands) using an
expiratory gas analysis machine (Vmax-295, SensorMedics Co.,
Yorba Linda, CA, USA). After a period of resting, warm-up was
performed for a few minutes at 20 W,  followed by ramp load-
ing (15 W/min) until subjective exhaustion, progressive angina,
ST-segment depression (≥2 mm),  or sustained tachyarrhythmia.
The point of AT was  determined by the “V-slope” method.
Statistical analyses
The results are expressed as mean ± standard deviation and
were analyzed using the StatView software (Version 5.0J for Win-
dows, SAS Institute, Cary, NC, USA). Comparisons between the DM
and non-DM groups were performed by Student’s t-test. Data at
baseline and after 6 months of CR were compared for each patient
by paired t-test to evaluate the singular effects of CR. Correlation
coefﬁcients were determined by linear regression analysis. Statis-
tical signiﬁcance of correlation coefﬁcients was determined by the
method of Fisher and Yates. A p-value of less than 0.05 was consid-
ered signiﬁcant.
Results
Characteristics of CR subjects
The clinical characteristics of the subjects are presented in
Table 1. Thirty-seven patients were diagnosed as having DM. No
signiﬁcant differences with regard to age, gender, coronary risk
factors, number of diseased vessels, ejection fraction, or physiologi-
cal variables, were observed between the DM and non-DM groups.
Thirty-six patients received complete revascularization using the
off-pump operation. One patient who had received re-CABG was
in the DM group. No signiﬁcant differences in the concomitantExercise in hospital (times) 16 ± 14 18 ± 14 NS
Data are presented as the mean value ± SD. DM,  diabetes mellitus; MI,  myocardial
infarction; PCI, percutaneous coronary intervention; CABG, coronary arterial bypass
grafting; LMT, left main trunk; VD, vessel disease.
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ere treated with oral anti-diabetic agents and insulin, respec-
ively. No signiﬁcant differences were observed between the two
roups in exercise duration in the CR program (data not shown).
o subject in either group showed any worsening of symptoms or
ad cardiovascular events during the 6 months of the study.
erum lipid proﬁles and glucose parameters
Serum lipid proﬁles and glucose parameters at baseline and the
nd of CR are presented in Table 2. Fasting blood glucose and HbA1c
evels before and after CR were signiﬁcantly higher in the DM group
han in the non-DM group (both p < 0.05). Lipid proﬁles were not
igniﬁcantly different between the two groups at both baseline and
he end of CR.
nthropometric parameters
The anthropometric parameters at baseline and after CR in
oth groups are presented in Table 3. The anthropometric param-
ters at baseline were not signiﬁcantly different between the two
roups. In the non-DM group, waist circumference (from 84.5 ± 7.8
o 82.2 ± 6.7 cm,  p < 0.05) was signiﬁcantly decreased, and thigh cir-
umference (from 48.9 ± 4.1 to 50.7 ± 3.7 cm,  p < 0.05), arm forced
ircumference (from 29.0 ± 2.6 to 30.0 ± 2.4 cm,  p < 0.05), mid-
pper arm muscle circumference (from 25.7 ± 2.5 to 26.5 ± 2.4 cm,
 < 0.05), and MAMA  (from 53.2 ± 10.3 to 56.5 ± 10.0 cm2, p < 0.05)
ere signiﬁcantly increased. In the DM group, waist circumfer-
nce (from 83.4 ± 8.3 to 80.2 ± 5.7 cm,  p < 0.05) was  signiﬁcantly
ecreased, however, thigh circumference, arm forced circumfer-
nce, mid-upper arm muscle circumference, and MAMA  were
ot signiﬁcantly altered. At the end of CR, thigh circumference
47.3 ± 2.5 cm vs. 50.7 ± 3.7 cm,  p < 0.05), arm forced circumference,
28.4 ± 1.6 cm vs. 30.0 ± 2.4 cm,  p < 0.05), mid-upper arm mus-
le circumference (25.0 ± 1.8 cm vs. 26.5 ± 2.4 cm,  p < 0.05), and
able 2
omparison of glucose, lipid, and other parameters between the DM and non-DM groups
DM group (n = 37) 
Baseline 
Fasting blood glucose (mg/dl) 143 ± 57 
HbA1c  (%) (JDS) 7.0 ± 1.3 
LDL-C  (mg/dl) 116 ± 37 
HDL-C  (mg/dl) 48 ± 15 
TG  (mg/dl) 161 ± 97 
Creatinine (mg/dl) 1.4 ± 2.3 
CRP  (mg/dl) 0.6 ± 1.4 
ata are presented as the mean value ± SD. DM,  diabetes mellitus; HbA1c, hemoglobin 
holesterol; TG, triglycerides; CRP, C-reactive protein.
p < 0.05 compared with at baseline.
*p < 0.05 compared with the DM group at baseline.
p < 0.05 compared with the DM group after 6 months.
able 3
omparison of anthropometric parameters between the DM and non-DM groups.
DM group (n = 37)
Baseline 
Body mass index (kg m−2) 23.3 ± 2.7 
Lean  body weight (kg) 48.4 ± 9.8 
Waist  circumference (cm) 83.4 ± 8.3 
Thigh circumference (cm) 47.2 ± 4.3 
Arm forced circumference (cm) 28.3 ± 2.7 
Mid-upper arm muscle circumference (cm) 24.9 ± 2.4 
Mid-upper arm muscle area (cm2) 49.7 ± 9.5 
ata are presented as the mean value ± SD. DM,  diabetes mellitus.
* p < 0.05 compared with at baseline.
# p < 0.05 compared with the DM group after 6 months.diology 61 (2013) 216–221
MAMA  (49.9 ± 7.1 cm2 vs. 56.5 ± 10.0 cm2, p < 0.05) were signiﬁ-
cantly lower in the DM group than in the non-DM group.
Exercise tolerance and muscle strength
Exercise tolerance and muscle strength at baseline and
after CR in each group are presented in Table 4. At the begin-
ning of CR, the levels of peak VO2 (13.7 ± 4.0 ml  kg−1 min−1 vs.
16.0 ± 4.7 ml  kg−1 min−1, p < 0.05) and thigh muscle strength
(136.3 ± 42.7 Nm kg−1 × 100 vs. 162.7 ± 47.9 Nm kg−1 × 100,
p < 0.05) were signiﬁcantly lower in the DM group than in the
non-DM group. No signiﬁcant differences in HGP (28 ± 9 kg
vs. 31 ± 9 kg, NS) were observed between the two groups. At
the end of CR, both groups showed signiﬁcant improvements
in exercise tolerance and muscle strength. Improvements in
exercise tolerance and muscle strength were identical in the
DM and non-DM groups. However, the levels of peak VO2
(19.4 ± 3.8 ml  kg−1 min−1 vs. 22.9 ± 5.4 ml  kg−1 min−1, p < 0.05)
and AT (11.3 ± 2.2 ml kg−1 min−1 vs. 13.3 ± 3.4 ml  kg−1 min−1,
p < 0.05) were still signiﬁcantly lower in the DM group than
in the non-DM group. The levels of thigh Ext muscle strength
(164.1 ± 43.3 Nm kg−1 ×100 vs. 193.3 ± 51.9 Nm kg−1 × 100,
p < 0.05) and HGP (30 ± 7 kg vs. 35 ± 8 kg, p < 0.05) were also
signiﬁcantly lower in the DM group than in the non-DM group.
Correlations between muscle mass, muscle strength, and HbA1c
At the end of CR, the values for thigh muscle strength were
correlated with thigh circumference (r = 0.44, p < 0.01) and MAMA
(r = 0.37, p < 0.05) (Fig. 1). The values of HGP were correlated
with thigh circumference (r = 0.52, p < 0.01), and MAMA  (r = 0.48,
p < 0.05) (Fig. 1). The same trends were observed at the beginning
of CR [9].  Moreover, the percent change in Ex muscle strength was
.
Non-DM group (n = 41)
After Baseline After
167 ± 68 103 ± 14 112 ± 20
7.2 ± 1.4 5.1 ± 0.4 5.2 ± 0.5
97 ± 22 124 ± 40 89 ± 16
50 ± 14 51 ± 12 49 ± 12
168 ± 191 149 ± 66 158 ± 97
1.1 ± 1.3 0.8 ± 0.2 0.8 ± 0.2
0.6 ± 1.3 0.2 ± 0.2 0.7 ± 2.0
A1c; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein
Non-DM group (n = 41)
After Baseline After
22.6 ± 1.9 23.4 ± 2.9 23.7 ± 2.5
45.2 ± 5.2 49.4 ± 7.7 49.6 ± 7.3
80.2 ± 5.7* 84.5 ± 7.8 82.2 ± 6.7*
47.3 ± 2.5 48.9 ± 4.1 50.7 ± 3.7*,#
28.4 ± 1.6 29.0 ± 2.6 30.0 ± 2.4*,#
25.0 ± 1.8 25.7 ± 2.5 26.5 ± 2.4*,#
49.9 ± 7.1 53.2 ± 10.3 56.5 ± 10.0*,#
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Table  4
Comparison of exercise tolerance and muscle strength between the DM and non-DM groups.
DM group (n = 37) Non-DM group (n = 41)
Baseline After Baseline After
Anaerobic threshold (ml  kg−1 min−1) 8.3 ± 1.6 11.3 ± 2.2* 9.7 ± 2.7 13.3 ± 3.4*,#
Peak VO2 (ml  kg−1 min−1) 13.7 ± 4.0 19.4 ± 3.8* 16.0 ± 4.7** 22.9 ± 5.4*,#
Anaerobic threshold workload (W)  34 ± 15 52 ± 21* 39 ± 20 66 ± 22*,#
Peak workload (W) 73 ± 23 107 ± 21* 81 ± 29 124 ± 29*,#
Knee extension (Nm kg−1 × 100) 136.3 ± 42.7 164.1 ± 43.3* 162.7 ± 47.9** 193.3 ± 51.9*,#
Knee ﬂexion (Nm kg−1 × 100) 80.0 ± 26.7 102.4 ± 30.3* 91.2 ± 29.2 115.1 ± 30.7*
Power of hand grip (kg) 28 ± 9 30 ± 7* 31 ± 9 35 ± 8*,#
Data are presented as the mean value ± SD. DM,  diabetes mellitus.
* p < 0.05 compared with at baseline.
** p < 0.05 compared with the DM group at baseline.
# p < 0.05 compared with the DM group after 6 months.
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Fig. 1. Correlations between muscle strength and muscle mass. At the end of cardiac rehabilitation, the levels of muscle strength of thigh were correlated with thigh
c HGP w
p
c
p
D
o
e
n
C
w
iircumference (r = 0.44, p < 0.01) (A) and MAMA  (r = 0.37, p < 0.05) (C). The values of 
 < 0.05) (D). MAMA,  mid-upper arm muscle area; HGP, hand grip power.
orrelated with MAMA  (r = 0.47, p < 0.005) and HbA1c (r = −0.41,
 < 0.05) (Fig. 2).
iscussion
In the present study, we demonstrated that: (1) the levels
f muscle strength and exercise tolerance at the beginning and
nd of CR were signiﬁcantly lower in the DM group than in the
on-DM group; (2) exercise tolerance and muscle strength after
R were signiﬁcantly improved in both groups; (3) muscle mass
as signiﬁcantly increased after CR in the non-DM group, but not
n the DM group; and (4) percent change in muscle strength wasere correlated with thigh circumference (r = 0.52, p < 0.01) (B), and MAMA  (r = 0.48,
correlated with that of HbA1c in patients undergoing CR after
CABG. Our group and others previously reported a relationship
between muscle strength and peak VO2 in patients with cardio-
vascular disease [15,16]. However, to the best of our knowledge,
this is the ﬁrst report to simultaneously demonstrate the effects of
CR on muscle mass, muscle strength, and exercise tolerance, and
to compare DM and non-DM patients undergoing CR after CABG.
CR is described as a class I recommendation in most contem-
porary cardiovascular clinical practice guidelines. Following CR,
patients show increased exercise tolerance and muscle strength,
which have proven to be the strongest predictors of the risk of
death among subjects both with and without known cardiovas-
cular disease [17,18]. Boulé et al. reported in a meta-analysis that
220 M.  Nishitani et al. / Journal of Cardiology 61 (2013) 216–221
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oig. 2. Correlations between percent change in muscle strength and those in MAM
nd  those in MAMA  was observed (r = 0.47, p < 0.005) (A). A signiﬁcant inverse relat
r  = −0.41, p < 0.05) (B). % EXT, percent change of knee extension; % MAMA, percent
tructured exercise training in DM patients achieved an 11.8%
ncrease in peak VO2 [19]. This is particularly important, because
n improvement in peak VO2 of 1.44 ml  kg−1 min−1 was equivalent
o a 7.9% reduction in overall mortality [20]. Moreover, exercise has
any potential beneﬁts, including not only improving exercise tol-
rance, but also improving glucose metabolism, insulin signaling,
ipid proﬁle, endothelial function, and blood pressure, reducing
ascular inﬂammation and facilitating weight maintenance [7].
ither aerobic or resistance training alone improves glycemic con-
rol in DM patients, however, a combination of both may  be more
eneﬁcial for improving risk factors than each alone [18]. Williams
t al. have reported a combination of aerobic and resistance train-
ng exercise improved through neuromuscular adaptation, muscle
ber hypertrophy, and increased muscle oxidative capacity [21].
 previous study demonstrated the beneﬁcial effects of resistance
raining on muscle mass and strength in chronic heart failure [18].
e also reported that CR with aerobic and resistance training had
eneﬁcial effects not only on the modiﬁcation of metabolic risk fac-
ors, but also on improvement in exercise tolerance and muscular
trength in patients with metabolic syndrome following CABG [12].
Levels of exercise tolerance and muscle strength were lower in
M than in non-DM patients in the present study. A previous report
howed that endothelial dysfunction associated with high glucose
evels is caused by the increased production of vasoconstrictor
rostanoids as a consequence of protein kinase C activation [22].
ther studies have demonstrated that DM patients have impaired
etabolism of both glucose and fatty acids in skeletal muscles. In
ddition, the bioenergetic capacity of skeletal muscle mitochon-
ria was found to be impaired in DM patients [23]. We  previously
bserved a signiﬁcant inverse relationship between fasting glu-
ose levels and thigh muscle strength at the beginning of CR in
M patients after CABG [9].
The DM group showed no increase in muscle mass such as
AMA  and thigh circumference (Table 3), both of which corre-
ated with thigh muscle strength and HGP (Fig. 1). Vergès et al.
eported that the effects of CR on exercise capacity were signif-
cantly lower in DM than in non-DM patients, and the response
o CR was inﬂuenced by blood glucose levels [7].  Moreover, we
howed a signiﬁcant inverse relationship between percent change
or HbA1c and that for thigh muscle strength in the DM group
Fig. 2). Park et al. demonstrated that functional muscle quality
as relatively low in DM patients. Furthermore, long duration of
iabetes and poor glycemic control were associated with deteri-
ration in muscle quality. Diabetes with poor glycemic control is HbA1c. A signiﬁcant relation between the percent change in the muscle strength
tween the percent change in the muscle strength and those in HbA1c was observed
e of mid-upper arm muscle area; % HbA1c, percent change of hemoglobin A1c.
related to the presence and severity of peripheral neuropathy and
inﬂammatory cytokines, which have detrimental effects on muscle
function [8].  Chronic hyperglycemia induces a condition of oxida-
tive stress that is causally involved in the development of skeletal
muscle depletion [24]. The increased production of reactive oxy-
gen species induced by hyperglycemia has also been suggested
to be involved in the redox regulation of glucose transport in
skeletal muscle [25]. Hyperglycemia leads to the production of
Amadori products between glucose and reactive amino groups of
serum proteins [26]. These products undergo further irreversible
reactions to form advanced glycation end products that promote
insulin resistance and trigger inﬂammation, which leads to diabetic
vascular complications [26]. The DM group had 11.0 ± 6.7 years’
duration of DM history in the present study, and the prevalence of
microvascular complications, including retinopathy, nephropathy,
and neuropathy was 38%. These data may  explain the mechanisms
by which improvements in muscle mass and strength, and exercise
tolerance, were impaired in the DM group. Thus, not only exercise
but also glycemic control may  be important in improving muscle
structure.
Several studies have shown a U-shaped association between
BMI  and mortality. Increased risk was independent of abdominal
and general obesity, and lifestyle and cardiovascular risk factors
such as blood pressure and lipid levels were related to early car-
diovascular morbidity and mortality. Additionally, Heitmann et al.
reported that this risk was  related more to thigh than waist circum-
ference [13]. A study in a cohort of community-dwelling Japanese
elderly demonstrated that low arm muscle area was an indepen-
dent risk factor for 2-year mortality [27]. We would like to clarify
whether arm muscle area after CR can predict morbidity and mor-
tality in DM patients after CABG.
There are some limitations to the present study. First, because
this was a single-center study with a small sample size, studies of
larger sample size are required to conﬁrm these ﬁndings. Second,
the exercise session at the outpatient clinic was encouraged once a
week with at least 2 exercise sessions at home. However, while the
mean number of CR sessions in hospital was  16–18 times, we have
no data regarding home-based exercise frequency and intensity for
either group, and we need to assess the effects of exercise frequency
and intensity in a future study. The program used in this study
may  not have been sufﬁciently rigorous to alter parameters such
as glucose control and lipid proﬁles. Third, we  enrolled patients
undergoing CR after CABG. Therefore, the results may  not necessar-
ily be representative of all DM patients with CAD. In a future study,
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e need to investigate DM patients undergoing percutaneous
ntervention and/or those with acute coronary syndrome. Finally,
e need to investigate whether different treatments, including
ntensive glucose control and a combination of aerobic and resis-
ance training, can enhance muscle mass and ameliorate future
ardiovascular events and long-term mortality in DM patients after
ABG.
onclusions
Patients with DM had lower muscle strength and lower exer-
ise tolerance than non-DM patients at the beginning of CR after
ABG. Both groups showed improved exercise tolerance and mus-
le strength after undergoing CR. However, DM patients had lower
uscle mass, lower muscle strength, and lower exercise tolerance
han non-DM patients at the end of CR. Moreover, improvement in
uscle strength may  be inﬂuenced by changes in muscle mass and
igh glucose levels in DM patients. Further studies are needed to
ssess whether a CR program including muscle mass intervention
nd aggressive glucose control would improve muscle mass and
meliorate future cardiovascular events in DM patients after CABG.
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